Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 October, 2018 19:49 IST
Vivimed Labs acquires Hungary based CDMO biz Soneas
Source: IRIS | 16 May, 2018, 12.14PM
Comments  |  Post Comment

Vivimed Labs Spain S.L, the parent of UQUIFA S.A, has signed definitive agreements to facilitate the acquisition of SONEAS, a Budapest (Hungary) head quartered CDMO company, focussed on the Inriovator Pharmaceutical and Fine Chemical sectors.

The business has been acquired from Lochlomond and Euroventures which are both based out of Hungary. SONEAS has for the year 2017, reported revenues of Euro 12.2 million.

The acquisition broadens UQUIFA's market offering in the CDMO space by enhancing its ability to now undertake preclinical, phase I, 11 and III NCE project development. These projects can then also potentially feed into UQUIFA's existing cGMP inspected and approved manufacturing facilities in Spain and Mexico, creating a high-value project pipeline.

Shares of the company gained Rs 2.1, or 3.18%, to trade at Rs 68.10. The total volume of shares traded was 73,620 at the BSE (12.01 p.m., Wednesday).





Vivimed Labs Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Zydus receives USFDA's final approval for Clobazam tablets - 23-Oct-2018 15:01
Ahluwalia Contracts wins new orders of worth Rs 5.38 bn - 23-Oct-2018 11:58
PNB Housing Finance raises Rs 17.75 bn through commercial papers - 23-Oct-2018 10:22
White Organic Agro bags additional orders from Innovative Cuisine - 23-Oct-2018 10:16
Himachal Futuristic Communications secures order worth Rs 3.66 bn - 23-Oct-2018 10:07
Lupin gets nod for generic Triamcinolone Acetonide ointment - 23-Oct-2018 10:00
ITD Cementation India bags orders worth Rs 10.66 bn - 23-Oct-2018 09:35
Biocon, Mylan announce positive CHMP Opinion for Ogivri - 22-Oct-2018 10:28
Lupin announces positive CHMP opinion for NaMuscla - 22-Oct-2018 09:51
Tejas Networks bags Rs 1.11 bn order from Sterlite Technologies - 22-Oct-2018 09:45
Alembic Pharma' JV completes USFDA inspection of Karakhadi unit - 22-Oct-2018 09:41
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer